期刊文献+

α糖苷酶抑制剂阿卡波糖治疗IGT的临床观察 被引量:1

暂未订购
导出
摘要 目的:通过α糖苷酶抑制剂阿卡波糖治疗IGT(糖耐量低减),探讨药物干预的办法积极治疗IGT的可行性。方法:对筛查出IGT的35例患者除进行生活方式的干预外,给予阿卡波糖50~100mg,三餐中服用,8周后观察干预前后血糖、血浆胰岛素变化。结果:服用阿卡波糖后餐后血糖明显下降(P<0.01),餐后胰岛素水平已明显降低(P<0.01)。结论:IGT患者除了生活方式的干预外,药物如α糖苷酶抑制剂口服应该是一个更积极的措施。
作者 赵滨 沈广威
出处 《中国医药导报》 CAS 2009年第16期86-86,89,共2页 China Medical Herald
  • 相关文献

参考文献5

二级参考文献23

  • 1陈家伦.新一代治疗糖尿病的药物──阿卡波糖[J].中华内分泌代谢杂志,1995,11(3):170-173. 被引量:53
  • 2潘长玉,中华医学杂志,1995年,75卷,409页
  • 3潘孝仁,中华内分泌代谢杂志,1989年,5卷,20页
  • 4The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus.Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus.Diabetes Care,1997,20:1183-1197.
  • 5World Health Organisation.Definition,Diagnosis,and Classification of Diabetes Mellitus and its Complications.Report of a WHO consultation.Part l:Diagnosis and Classification of Diabetes Mellitus.Geneva:World Health Organisation,1999.
  • 6American Diabetes Association.The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus:Follow-up report on the diagnosis of diabetes mellitus.Diabetes Care,2003,26:3160-3167.
  • 7Weyer C,Bogardus C,Pratley RE.Metabolic characteristics of individuals with impaired fasting glucose and/or impaired glucose tolerance.Diabetes,1999,48:2197-2203.
  • 8DECODE Study Group on behalf of the European Diabetes Epidemiology Study Group.Will new diagnostic criteria for diabetes mellitus change phenotype of patients with diabetes? Reanalysis of European epidemiological data.Br Med J,1998,317:371-375.
  • 9Tripathy D,Carlsson M,Almgren P,et al.Insulin secretion and insulin sensitivity in relation to glucose tolerance:lessons from the Botnia Study.Diabetes.2000,49:975-980.
  • 10DECODE Study Group on behalf of the European Diabetes Epidemiology Group.Age,body mass index and glucose tolerance in 11 European population-based surveys.Diabetic Medicine,2002,19:558-565.

共引文献85

同被引文献19

引证文献1

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部